MEK INHIBITOR-ASSOCIATED SEROUS RETINOPATHY

MEK INHIBITOR-ASSOCIATED SEROUS RETINOPATHY was reported 4 times

MEK INHIBITOR-ASSOCIATED SEROUS RETINOPATHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Fluoroquinolone Antibacterial [EPC] 1 0.0000
1 Thiazide Diuretic [EPC] 1 0.0000
2 Kinase Inhibitor [EPC] 2 0.0000
3 Corticosteroid [EPC] 1 0.0000